
Morgan Stanley has officially disclosed its first known investment in XRP through the acquisition of shares in the Volatility Shares XRP ETF and the Grayscale XRP ETF. This strategic move underscores a growing institutional appetite for regulated cryptocurrency investment products linked to the Ripple ecosystem. Simultaneously, Ripple Labs has experienced a significant valuation increase, with its private shares surging 376% to reach $136.90. This valuation spike, supported by a $750 million share buyback program, suggests strong market confidence ahead of a potential initial public offering in 2026. Despite these positive institutional developments, XRP has faced broader market volatility, recording a monthly decline of approximately 4.85% to trade near $1.30. The wider cryptocurrency market remains cautious as traders navigate the expiration of nearly $7.5 billion in crypto options. While Bitcoin and Ethereum have shown signs of recovery following geopolitical stabilization, XRP continues to react to both macroeconomic factors and specific corporate developments within the Ripple network.
AI-generated summary — read the full article at the source for complete details.